U
CCM

UBS’s Concord Medical Services CCM Stock Holding History

UBS’s Portfolio CCM Stock Details CCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-57
Closed -$3K – 10416
2013
Q3 		$3K Buy
+57
New +$2.33K ﹤0.01% 9736

Other funds holding CCM

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS's CCM Position: Q3 2014 in Review

UBS increased its Concord Medical Services (CCM) stake by 54% in Q3 2014, buying an estimated $5.34K and bringing the position to 192 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #8514.

UBS first reported a position in CCM in Q2 2013 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold CCM as of Q3 2014.

  • UBS held 192 shares of Concord Medical Services worth $13K as of Q3 2014.
  • UBS bought 67 Concord Medical Services shares in Q3 2014, an estimated $5.34K.
  • Concord Medical Services made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8514 holding.
  • UBS first reported a position in Concord Medical Services in Q2 2013 and has held it in 6 quarters since.
  • 28 funds tracked by Wall St. Rank held Concord Medical Services as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.